CONMED Corporation (CNMD)
Gross profit margin
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Gross profit | US$ in thousands | 733,032 | 676,245 | 571,245 | 568,036 | 460,300 |
Revenue | US$ in thousands | 1,307,020 | 1,244,740 | 1,045,470 | 1,010,640 | 862,459 |
Gross profit margin | 56.08% | 54.33% | 54.64% | 56.21% | 53.37% |
December 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $733,032K ÷ $1,307,020K
= 56.08%
The gross profit margin of CONMED Corporation has shown a positive trend over the past five years, starting at 53.37% as of December 31, 2020, and increasing consistently to reach 56.08% as of December 31, 2024. This indicates that the company has been effectively managing its production costs and generating a higher percentage of profits from its sales.
The improvement in the gross profit margin signifies that CONMED has been able to maintain pricing power, control manufacturing expenses, or improve operational efficiency during this period. This trend is a positive indicator of the company's ability to generate more profit for each dollar of sales made. It also suggests that CONMED may have a competitive advantage in its industry compared to its peers.
Overall, the rising gross profit margin of CONMED Corporation reflects strong financial management and operational performance, which can contribute to sustainable growth and profitability in the long term. Further analysis of other financial metrics and factors would provide a more holistic view of the company's financial health and performance.
Peer comparison
Dec 31, 2024